Darktrace
VerifiedProvides enterprise immune system technology for cyber security that prevents and eliminates insider threats.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$5.0b (Public information from Jul 2024)
Share price
£5.86824 DARK.L
Company register number 08562035
Cambridge England (HQ)
Financials
Estimates*
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 199m | 281m | 415m | 545m | 685m | 830m | 991m |
| % growth | - | 41 % | 48 % | 31 % | 26 % | 21 % | 19 % |
| EBITDA | (2.0m) | (18.0m) | 42.5m | 85.4m | 159m | 195m | 236m |
| % EBITDA margin | (1 %) | (6 %) | 10 % | 16 % | 23 % | 24 % | 24 % |
| Profit | (28.7m) | (150m) | 1.5m | 59.0m | 75.3m | 91.8m | 106m |
| % profit margin | (14 %) | (53 %) | - | 11 % | 11 % | 11 % | 11 % |
| EV / revenue | - | 13.3x | 4.6x | 4.1x | 6.5x | 5.2x | 4.2x |
| EV / EBITDA | - | -207.1x | 45.3x | 25.9x | 28.0x | 22.1x | 17.6x |
| R&D budget | 12.0m | 28.8m | 44.3m | 47.9m | - | - | - |
| R&D % of revenue | 6 % | 10 % | 11 % | 9 % | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
N/A | Seed | ||
* | $18.0m Valuation: $80.0m | Series A | |
* | $22.5m Valuation: $100m | Series B | |
* | $65.0m Valuation: $400m | Growth Equity VC | |
* | $75.0m Valuation: $825m | Series D | |
N/A | Secondary | ||
N/A | Support Program | ||
N/A Valuation: $1.3b | Secondary | ||
$50.0m Valuation: $1.7b | Series E | ||
| N/A | £165m Valuation: £1.7b 11.3x EV/LTM Revenues -1101.6x EV/LTM EBITDA | IPO | |
* | $5.3b | Acquisition | |
| Total Funding | $230m | ||
Recent News about Darktrace
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Darktrace
Edit
ACQUISITION by Darktrace Feb 2022